Upon activation, we observed altered transcription of KITLG, TGFB1, IFNG, SPP1, IL17A and PDCD1, whose associated functions and expression pattern marked and improved OS of BrC patients, supporting that MCs contribute with a tumor stroma with anti-tumoral functions in BrC. The gene discussed is KITLG; the disease is neoplasm.